Neurogene Inc (NGNE)

Jul 23, 2025

Is Neurogene Inc. a good long term investmentHigh-yield portfolio picks - Autocar Professional

Jul 23, 2025

Jul 23, 2025

What drives Neurogene Inc. stock priceMarket-crushing profits - Autocar Professional

Jul 23, 2025

Jul 22, 2025

Neurogene Inc. Stock Analysis and ForecastSuperior portfolio returns - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What analysts say about Neurogene Inc. stockFree Market Dynamics Reports - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What makes Neurogene Inc. stock price move sharplyReal Time Stock Signal - Newser

Jul 22, 2025

Jul 18, 2025

how neurogene inc. stock performs during market volatilityDefensive Stock Picks with Upside - Newser

Jul 18, 2025

Jul 15, 2025

How Neurogene Inc. stock performs during market volatilityHigh Return Conservative Stocks - Newser

Jul 15, 2025

Jul 15, 2025

Why Neurogene Inc. stock attracts strong analyst attentionFree Investment Community - Newser

Jul 15, 2025

Jul 05, 2025

Neurogene announces inducement grants - Medical Buyer

Jul 05, 2025

Jul 03, 2025

Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Jul 03, 2025

Jul 03, 2025

Neurogene Inc. (NASDAQ:NGNE) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World

Jul 03, 2025

Jul 01, 2025

Neurogene jumps as FDA approves rare gene therapy trial design - TradingView

Jul 01, 2025

Jul 01, 2025

Stifel reiterates Buy rating on Neurogene stock, backs pivotal trial design - Investing.com

Jul 01, 2025

Jun 30, 2025

FDA approves Neurogene’s Rett syndrome gene therapy registrational trial design - Investing.com

Jun 30, 2025

Jun 30, 2025

Neurogene Announces Registrational Trial Design for Embolden™ Study of NGN-401 Gene Therapy for Rett Syndrome - Business Wire

Jun 30, 2025

Jun 30, 2025

Neurogene Inc.(NasdaqGM: NGNE) dropped from Russell 3000E Growth Index - MarketScreener

Jun 30, 2025

Jun 18, 2025

Craig-Hallum bullish on Neurogene, initiates with a Buy - Yahoo Finance

Jun 18, 2025

Jun 18, 2025

Neurogene (NASDAQ:NGNE) Coverage Initiated by Analysts at Craig Hallum - Defense World

Jun 18, 2025

Jun 17, 2025

Neurogene (NGNE) Receives New Buy Rating from Craig-Hallum | NGN - GuruFocus

Jun 17, 2025

Jun 17, 2025

Neurogene (NGNE) Gains Attention with Promising Gene Therapy for - GuruFocus

Jun 17, 2025

Jun 17, 2025

Neurogene (NGNE) Receives Positive Coverage with a $50 Price Tar - GuruFocus

Jun 17, 2025

Jun 17, 2025

Neurogene (NGNE) Gains Attention with Promising Gene Therapy for Rett Syndrome | NGNE Stock News - GuruFocus

Jun 17, 2025

Jun 14, 2025

Neurogene Reports First Quarter 2025 Financial Results and Highlights Recent Updates - Investing.com Nigeria

Jun 14, 2025

Jun 13, 2025

BMO Capital Markets Issues Positive Forecast for Neurogene (NASDAQ:NGNE) Stock Price - Defense World

Jun 13, 2025

Jun 13, 2025

Neurogene’s (NGNE) Outperform Rating Reaffirmed at BMO Capital Markets - Defense World

Jun 13, 2025

Jun 12, 2025

Neurogene (NGNE) Price Target Raised by BMO Capital | NGNE Stock News - GuruFocus

Jun 12, 2025